Precision Medicine - Invest in Manchester
First for IVF treatment

First for IVF treatment

Invest in Manchester

Precision Medicine

  1. Manchester, UK is where the treatment of leukaemia was revolutionised and its expertise in genomics, proteomics, imaging and biomarker discovery and development attracted over £100 million of grant income for precision medicine in recent years. The city region’s key research strengths across a range of chronic healthcare conditions include:

    - Oncology at the globally renowned Christie hospital – one of the first centres to introduce CAR-T therapy

    - Cardiovascular, respiratory and inflammatory conditions

    - Rich health analytics and wide-ranging digital strengths

    These specialisms provide life science and healthcare companies with the ideal environment to translate research into real-life solutions.

    Manchester is also 国际利来城home to the largest clinical academic campus in Europe with a deep concentration of proteogenomic expertise – a major factor in Qiagen’s decision to establish its European Centre of Excellence for precision medicine and hub for diagnostics delivery in the city and in launching APIS Assay Technologies, in conjunction with Health Innovation Manchester to develop biomarkers for diagnosing disease and pinpointing the treatments which are right for each individual patient.

    To find out what attracted businesses such as Qiagen to Manchester contact MIDAS, Greater Manchester’s inward investment agency, who will be able to connect you with leading research assets and help you build a business case to move to the city of firsts.


    Why Manchester?

    With a wealth of globally acclaimed academic and research centres and a uniquely devolved health and social care budget of £6 billion, Manchester’s community of precision medicine experts each provide unique skills and capabilities and are able to advance personalised medicine and assist companies with launching innovative products into the global market.


    A Huge Opportunity for Translational Research

    Health Innovation Manchester provides a coordinated pathway for new health care innovations to access the region’s healthcare system. The Stoller Marker Discovery Centre provides an unparalleled opportunity for translational research offered through The Christie - a European leader in cancer care treating 44,000 patients a year with one of the largest clinical trial portfolios in the UK - and its partnership with The Manchester Molecular Pathology Innovation Centre (MMPathIC), part of The National Institute for Health Research (NIHR). The NIHR takes ground-breaking research findings and puts them into clinical use so that patients can swiftly benefit from innovation.

    Other research facilities include The Willink Metabolic Unit and  The Manchester Centre for Genomic Medicine (MCGM) at The MFT - one of 13 genomic medicine centres in the UK and one of the largest genetics units in Europe which develops new tests and supports the development of genetic services internationally. The Manchester Cancer Research Centre - one of five major CRUK research centres in the UK - investigates novel drug discovery and brings together the expertise of partner organisations across Greater Manchester and China, Australasia, North America and Europe.

    The Biological Mass Spectrometry core facility at The University of Manchester is a state-of-the-art resource for the identification, characterisation and quantification of proteins. Their highly experienced staff can provide companies who locate here with support for complicated projects to help perform or train on sample preparation and data analysis.

    Diagnostics and Technology Accelerator (DiTA) created by the MFT powers evidence generation for commercial biomarker and MedTech research enabling companies to rapidly prioritise, design and deliver both small and large-scale clinical evaluations of new technologies.


    Get in Touch

    Manchester’s established industry strengths, continual growth and its deep talent pool make it the perfect place for life science and healthcare firms to thrive. 

    To find out more about how Twitter and LinkedIn

  2. Talent
  3. Quality of Life
  4. Connectivity
  5. Digital Infrastructure

  6. Resources

     

    Global brands, SMEs and start-ups alike are thriving in Manchester thanks to the city’s outstanding connectivity, its international reputation for innovation and the wealth of expert talent available here. MIDAS – the city’s dedicated inward investment agency – has helped hundreds of businesses relocate to or expand into the city.

    Do you want to find out more about Manchester and how MIDAS can support your business relocation or expansion? Register here to receive useful resources about Manchester and MIDAS’ support package.


Follow MIDAS